12-Hydroxyeicosatetrenoate (12-HETE) Attenuates AMPA Receptor-Mediated Neurotoxicity: Evidence for a G-Protein-Coupled HETE Receptor
Open Access
- 1 January 2002
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 22 (1) , 257-264
- https://doi.org/10.1523/jneurosci.22-01-00257.2002
Abstract
12-Hydroxyeicosatetraenoic acid (12-HETE) is a neuromodulator that is synthesized during ischemia. Its neuronal effects include attenuation of calcium influx and glutamate release as well as inhibition of AMPA receptor (AMPA-R) activation. Because 12-HETE reduces ischemic injury in the heart, we examined whether it can also reduce neuronal excitotoxicity. When treated with 12-(S)HETE, cortical neuron cultures subjected to AMPA-R-mediated glutamate toxicity suffered up to 40% less damage than untreated cultures. The protective effect of 12-(S)HETE was concentration-dependent (EC50= 88 nm) and stereostructurally selective. Maximal protection was conferred by 300 nm12-(S)HETE; 300 nm15-(S)HETE was similarly protective, but 300 nm5-(S)HETE was less effective. The chiral isomer 12-(R)HETE offered no protection; neither did arachidonic acid or 12-(S)hydroperoxyeicosatetraenoic acid. Excitotoxicity was calcium-dependent, and 12-(S)HETE was demonstrated to protect by inactivating N and L (but not P) calcium channels via a pertussis toxin-sensitive mechanism. Calcium imaging demonstrated that 12-(S)HETE also attenuates glutamate-induced calcium influx into neurons via a pertussis toxin-sensitive mechanism, suggesting that it acts via a G-protein-coupled receptor. In addition, 12-(S)HETE stimulates GTPγS binding (indicating G-protein activation) and inhibits adenylate cyclase in forskolin-stimulated cultures over the same concentration range as it exerts its anti-excitotoxic and calcium-influx attenuating effects. These studies demonstrate that 12-(S)HETE can protect neurons from excitotoxicity by activating a Gi/o-protein-coupled receptor, which limits calcium influx through voltage-gated channels.Keywords
This publication has 50 references indexed in Scilit:
- Hydroxyeicosanoids Bind to and Activate the Low Affinity Leukotriene B4 Receptor, BLT2Journal of Biological Chemistry, 2001
- Therapeutic potential of ischaemic preconditioningBritish Journal of Clinical Pharmacology, 2000
- Is Pharmacological Neuroprotection Dependent on Reduced Glutamate Release?Stroke, 2000
- Ischemic Preconditioning and Brain Tolerance: Temporal Histological and Functional Outcomes, Protein Synthesis Requirement, and Interleukin-1 Receptor Antagonist and Early Gene ExpressionStroke, 1998
- Actions of general anaesthetics and arachidonic acid pathway inhibitors on K+ currents activated by volatile anaesthetics and FMRFamide in molluscan neuronesBritish Journal of Pharmacology, 1998
- Bidirectional modulation of AMPA receptor properties by exogenous phospholipase A2 in the hippocampusHippocampus, 1998
- Glutamate toxicity in neuron-enriched and neuron–astrocyte co-cultures: effect of the glutamate uptake inhibitor ?-trans-pyrrolidine-2,4-dicarboxylateNeurochemistry International, 1997
- Localization of Arachidonate 12‐Lipoxygenase in Canine Brain TissuesJournal of Neurochemistry, 1992
- Isolation and identification of lipoxygenase products from the rat central nervous systemBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
- Ischemic brain edema following occlusion of the middle cerebral artery in the rat. II: Alteration of the eicosanoid synthesis profile of brain microvessels.Stroke, 1985